This post‐translational modification leads to reduced IGF2BP1 levels in HCC, correlating with poor patient prognosis.[149] Moreover, FBXO45 enhances liver tumorigenesis by promoting the ubiquitination and subsequent activation of IGF2BP1 at Lys190 and Lys450. This evidence concerns the gene IGF2BP1 and hepatocellular carcinoma.